News 
Market Data 
Discover
Replies to post #94039 on Quantum Materials Corp. (fka QTMM)
10/01/20 5:26 PM
Heathrow has trialled three rapid point of care testing solutions on colleagues to understand how these tests might be quickly conducted outside of a laboratory.
In colleague testing trials, Heathrow worked with:
Geneme has proposed a rapid RT-LAMP test which uses a sample collected from a nasal or throat swab to provide results within 30 minutes. It uses a secure application from Yoti that simplifies the capture, processing and result sharing of Covid-19 tests, without needing paperwork. Secure spoof-proof results can be sent to an individual's phone using the free Yoti app or to a specified email.
Mologic has put forward a lateral flow solution which uses a saliva sample on a test which requires minimal equipment and is comparable to a pregnancy test.
I-Abra is working with the airport to trial their Virolens testing device to see whether its machine learning holographic microscope, backed by Dell/Intel and partnered with TT Electronics plc for design and manufacturing, can quickly (in under 30 seconds) and accurately identify whether a person is carrying the disease through a self-administered test.
Colleagues were given the option to choose which of the solutions they trialled. However, as the results of these initial trials are only advisory until the methodologies are proven to work in a non-clinical setting, participating colleagues also took a Government approved, privately provided PCR test, administered by Collinson Assistance Services Ltd. to compare their results to Government accredited tests.
